MOLECULAR THERAPY《分子治疗》(可网站投稿)

MOLECULAR THERAPY《分子治疗》(月刊). Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field.

杂志简称:mol ther
中文译名:《分子治疗》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:2.90%
投稿方向:医学、biotechnology & applied microbiology 生物工程与应用微生物、genetics & heredity 遗传学、medicine, research & experimental 医学、研究与实验

MOLECULAR THERAPY《分子治疗》

SCI/E期刊基本信息

出版周期:月刊 地区:美国
中科院分区:1区
是否TOP:TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN 1525-0016;EISSN1525-0024
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:50 HAMPSHIRE ST,FLOOR 5,CAMBRIDGE,USA,MA,02139
杂志邮箱:
投稿网址:https://www.editorialmanager.com/molecular-therapy/
杂志官方网址:https://www.cell.com/molecular-therapy-family/home
出版商网址:http://www.cell.com/cellpress

杂志投稿要求

期刊邮箱【杂志社官方网站信息】

Molecular Therapy

Editor-in-Chief

Roland W. Herzog, PhD

Professor of Pediatrics

Riley Children’s Foundation Professor of Immunology

Director, Gene and Cell Therapy Program

Herman B Wells Center for Pediatric Research

Indiana University

Indianapolis, IN 46202

Email: rwherzog@iu.edu

Executive Editor

Robert M Frederickson, PhD

Molecular Therapy Editorial Office

710 Summit Avenue East

Seattle, WA 98102

Tel: +1 323-989-7070

Email: editor@molther.org

Editorial Office

Editorial Questions: editor@molther.org

Technical Questions: journals@asgct.org

投稿须知【杂志社官方网站信息】

Molecular Therapy

Information for Authors

This page describes our policies and provides information that we think will be helpful to you as you prepare manuscripts for submission and publication. If you have submitted a paper and want information about the status of the paper, please log in to our online manuscript submission system. If you run into any problems or if you have specific questions, you can always email us at editor@molther.org.

Editorial Evaluation Timeline

We read and evaluate every submission, and we try our best to get back to you quickly. We are mindful of how long it can take to publish a paper, so we work with authors and reviewers to minimize that time. Here’s how long each step in the process usually takes:

Initial decision to review 3–5 days after submission

Time to first decision 3–4 weeks after submission

Time suggested for revision 2–3 months

Time to online publication of accepted manuscript*

3–5 days after acceptance

Time to online publication of final proofed manuscript

3–5 weeks from acceptance

Time to print publication Within 3 months of acceptance

*This time applies to OA articles only, not subscription.

Pre-submission Inquiries

Unsure if your paper is suitable for Molecular Therapy? Send us a pre-submission inquiry at editor@molther.org, and we’ll let you know in 2–5 days what we think. Please include a title, an abstract, and an explanation of why your paper is significant and broadly interesting.

Relationship between Molecular Therapy

Journals

Co-submission

If you think your paper might be suitable for two Molecular Therapy journals, you can submit the paper for joint consideration. To do this, upload your manuscript to one of the journals. In your cover letter, please indicate that you are seeking co-consideration and mention the name of the other journal.

Transfer of Papers between Molecular Therapy Journals

Although each Molecular Therapy journal is editorially independent, we have a system that allows you to transfer your manuscript, along with the reviews and the reviewers’ identities, from one journal to another. If you have questions about the suitability of your paper for transfer, please contact the editor of the receiving journal. Often, the Editor of the receiving journal will be able to reach a decision based on the existing reviews. Occasionally, the Editor may seek comments from additional reviewers. If you use our online system to transfer your paper, you will have a chance to edit your files before they are sent to the receiving journal. You can always submit your paper to another Molecular Therapy journal without mentioning the first review process. In this case, the manuscript will be evaluated as a regular new submission.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/48319

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午12:36
下一篇 2024年11月9日 下午12:36

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息